Anti–S1 IgG3 Ab levels after infection were generally low, with only 4 of 31 participants having OD > 0.1 (Figure 4D), but levels increased after first vaccination, with anti–S1 IgG3 Abs detected in 11 of 31 participants (Figure 4D). This evidence concerns the gene IGHG3 and infection.